Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Assessment of Eloquent Function in Brain Tumor Patients

Assessment of Reorganization and Plasticity of Eloquent Function in Patients With Brain Tumors

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Purpose of the study: AIM 1: Prospectively collect pre-operative \[functional magnetic resonance imaging (fMRI), diffusion tensor imaging (DTI), magnetoencephalography (MEG)\] and intra-operative mapping data in patients with intra-axial brain tumors to assess how well each modality predicts the location of eloquent brain function. In addition, each modality will be compared with the other. AIM 2: Assess reorganization of eloquent brain function and plasticity in patients with intra-axial brain tumors. This will be accomplished by prospectively collecting post-operative mapping studies and neuropsychological tests to compare them to prior mapping studies as stated above.

Who May Be Eligible (Plain English)

Who May Qualify: - 19 years and older - Brain tumor in or near eloquent brain regions that is appropriate for attempted resection - Appropriate body habitus and mental status/capacity to participate with non-invasive or invasive mapping - Benign or malignant intra-axial brain tumor - Primary or metastatic intra-axial brain tumor Who Should NOT Join This Trial: - Any contraindication to MRI (i.e. implanted devices) - Inappropriate body habitus or mental status/capacity to participate with non-invasive or invasive mapping in a safe and reliable manner - Declining to participate - Lacks capacity to understand the study or consent for themselves - Neurologic status which precludes testing (poor function- not testable) - Positive pregnancy test - End stage renal disease or severe renal dysfunction Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * 19 years and older * Brain tumor in or near eloquent brain regions that is appropriate for attempted resection * Appropriate body habitus and mental status/capacity to participate with non-invasive or invasive mapping * Benign or malignant intra-axial brain tumor * Primary or metastatic intra-axial brain tumor Exclusion Criteria: * Any contraindication to MRI (i.e. implanted devices) * Inappropriate body habitus or mental status/capacity to participate with non-invasive or invasive mapping in a safe and reliable manner * Declining to participate * Lacks capacity to understand the study or consent for themselves * Neurologic status which precludes testing (poor function- not testable) * Positive pregnancy test * End stage renal disease or severe renal dysfunction

Treatments Being Tested

DIAGNOSTIC_TEST

Brain mapping

Brain mapping will be employed pre-, intra-, and post-operatively to evaluate specific functions.

Locations (1)

University of Nebraska Medical Center
Omaha, Nebraska, United States